News
Zacks.com on MSN13d
Robust TMTT Growth to Drive Edwards Lifesciences' Q2 EarningsIn the last reported quarter, the company’s adjusted earnings per share of 64 cents beat the Zacks Consensus Estimate by 6.67 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback